GFPT2 reduction was also observed in a separate PD iPSn line that was previously characterized and accumulates pathological α-syn through a triplication in the SNCA genomic region (SNCA-3x)20 (Fig. S2B). The gene discussed is GFPT2; the disease is Parkinson disease.